Physician

Caleb J Smith, MD

According to 2025 Medicare claims, Caleb Smith, MD (NPI: 1891284030) practices hematology/oncology in the Columbia, MO market, with the plurality of this provider's patient population coming from Boone, MO. This provider's primary affiliated billing organization is MISSOURI CANCER ASSOCIATES LLC (NPI: 1215947338; TIN: 431763016) and primary practice location at 65201-7167. Smith is affiliated with the Mayo Clinic Community ACO, LLC (ACO ID: A4617), Aledade 98 MO MSSP Enhanced (ACO ID: A4998), Aledade 93 National MSSP Enhanced (ACO ID: A5206), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Smith's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 271 traditional Medicare patients, billed 21,337 HCPCS/CPT codes, and received $421,082 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 389 prescription claims across 88 beneficiaries totaling $387,226 in drug costs, led by Oxycodone Hcl (Oxycodone Hcl). 2022 DME data shows 14 claims. Open Payments data shows 16 records totaling $331. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $2,762 to $421,082. Similarly, Part D prescription costs have moved sharply higher in recent years, from $2,374 to $387,226. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	26	39	$2,762
2020	44	55	$2,733
2021	69	108	$10,731
2022	68	127	$14,345
2023	51	95	$9,364
2024	271	21,337	$421,082

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	20	51	$2,374
2019	47	243	$16,590
2020	91	331	$32,616
2021	65	234	$28,155
2022	33	137	$155,552
2023	20	110	$208,374
2024	88	389	$387,226

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	13	$1,239
2021	N/R	13	$1,179
2022	N/R	14	$1,184
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	39	39	$173
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	51	51	$123
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	80	125	$98
96413	Administration of chemotherapy into vein, 1 hour or less	36	43	$94
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	40	63	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Oxycodone Hcl	Oxycodone Hcl	50	520	$461
Dexamethasone	Dexamethasone	38	228	$453
Prochlorperazine Maleate	Prochlorperazine Maleate	30	223	$288
Letrozole	Letrozole	22	898	$240
Olanzapine	Olanzapine	28	781	$202

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	16	$331	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Caleb J. Smith, MD?

Tedicare shows public-source Medicare data for Caleb J. Smith, MD (NPI 1891284030), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Caleb J. Smith, MD have ACO affiliation data?

Caleb J. Smith, MD is shown with ACO affiliation data for Mayo Clinic Community ACO, LLC (MSSP, ACO ID A4617), Aledade 98 MO MSSP Enhanced (MSSP, ACO ID A4998), Aledade 93 National MSSP Enhanced (MSSP, ACO ID A5206), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Caleb J. Smith, MD?

Caleb J. Smith, MD is linked to MISSOURI CANCER ASSOCIATES LLC (billing NPI 1215947338) in the available physician profile data.

Does Caleb J. Smith, MD have Open Payments data?

Caleb J. Smith, MD has 16 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.